With a $4M federal grant, Lumen jumps into the Covid-19 treatment race

With a $4M federal grant, Lumen jumps into the Covid-19 treatment race

Source: 
Endpoints
snippet: 

It’s been less than a month since Lumen Bioscience announced a $16 million Series B to engineer spirulina — a nutrient-packed super food — for diseases like traveler’s diarrhea, norovirus and C. difficile colitis. And now, the biotech has pulled in another $4 million to do the same for Covid-19.